Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan C Gilbert

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|May 5, 2020
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)Jen Y Lee, Rosalind J Cutts, Ingrid White, et al.
Trials|May 11, 2021
Accessing routinely collected health data to improve clinical trials: recent experience of accessArchie Macnair, Sharon B Love, Macey L Murray, et al.
The Lancet. Oncology|May 4, 2023
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatmentEhsan Ghorani, Matteo Quartagno, Fiona Blackhall, et al.
The Journal of Pathology|November 22, 2017
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistanceJoanna Selfe, Neil C Goddard, Alan McIntyre, et al.
International Journal of Cancer|January 17, 2019
Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive diseaseJiafeng Pan, Kimberley Kavanagh, Kate Cuschieri, et al.
Frontiers in Oncology|January 18, 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignanciesPablo Nenclares, Adrian Larkeryd, Floriana Manodoro, et al.
BMC Pharmacology & Toxicology|January 24, 2026
Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trialsDuncan C Gilbert, Ruth E Langley, Dami Ayadi, et al.
BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.
Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.
Contemporary Clinical Trials|December 15, 2022
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancersSophie Merrick, Matthew Nankivell, Matteo Quartagno, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|May 5, 2020
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)Jen Y Lee, Rosalind J Cutts, Ingrid White, et al.
Trials|May 11, 2021
Accessing routinely collected health data to improve clinical trials: recent experience of accessArchie Macnair, Sharon B Love, Macey L Murray, et al.
The Lancet. Oncology|May 4, 2023
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatmentEhsan Ghorani, Matteo Quartagno, Fiona Blackhall, et al.
The Journal of Pathology|November 22, 2017
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistanceJoanna Selfe, Neil C Goddard, Alan McIntyre, et al.
International Journal of Cancer|January 17, 2019
Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive diseaseJiafeng Pan, Kimberley Kavanagh, Kate Cuschieri, et al.
Frontiers in Oncology|January 18, 2024
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignanciesPablo Nenclares, Adrian Larkeryd, Floriana Manodoro, et al.
BMC Pharmacology & Toxicology|January 24, 2026
Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trialsDuncan C Gilbert, Ruth E Langley, Dami Ayadi, et al.
BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.
Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.
Contemporary Clinical Trials|December 15, 2022
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancersSophie Merrick, Matthew Nankivell, Matteo Quartagno, et al.
Pageof 6